Septerna, Inc. (SEPN)
38.89
-0.24
(-0.61%)
USD |
NASDAQ |
Oct 01, 13:49
Septerna Shareholders Equity (Quarterly) : 386.72M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 386.72M |
| March 31, 2026 | 378.46M |
| December 31, 2025 | 381.93M |
| September 30, 2025 | 388.73M |
| June 30, 2025 | 377.56M |
| March 31, 2025 | 400.27M |
| Date | Value |
|---|---|
| December 31, 2024 | 420.05M |
| September 30, 2024 | 136.75M |
| June 30, 2024 | 156.39M |
| March 31, 2024 | |
| December 31, 2023 | 110.84M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 1.044M |
| CNBX Pharmaceuticals, Inc. | -2.660M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 562.20M |
| Fulcrum Therapeutics, Inc. | 310.70M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 566.74M |
| Total Liabilities (Quarterly) | 180.02M |
| Debt to Equity Ratio | 0.0583 |
| Current Ratio | 4.995 |
| Net Debt Paydown Yield | 0.03% |